Global Health Resources
This page provides details of organizations and resources relevant to the development of global health policies, agreements and alliances.
Academic Groups
- Duke Global Health Institute: brings together knowledge and resources from across Duke University to address the global health issues.
- Duke Kenan Center for Ethics: creates scholarly frameworks, policies, and practices to address moral challenges.
- Duke Trent Center for Bioethics, Humanities, & History of Medicine: connects scholars at Duke University interested in issues around medicine and its role in society.
- Global Access in Action (GAiA): convenes workshops, facilitates stakeholder engagement and publishes global health research, as well as providing assistance and guidance to developing countries.
- The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics Harvard Law School: center for health law policy, biotechnology, and bioethics.
Funders & Funder Policies
- Bill & Melinda Gates Foundation (global access statement): philanthropic foundation working with partners to tackle critical global problems in five program areas.
- CARB-X: organisation working to accelerate global antibacterial innovation by investing in the development of new antibiotics and other life-saving products to combat the most dangerous drug-resistant bacteria.
- Coalition for Epidemic Preparedness and Innovation (governance policies): funder and a facilitator focusing on vaccine development, licensure, and manufacturing.
- Donor Tracker: provides data-driven insights on countries’ strategic priorities, funding trends, and decision making processes.
- EU Innovative Medicines Initiative (intellectual property policy): EU public-private partnership funding health research and innovation.
- Global Health Innovative Technology Fund (access policy): public-private partnership fund for global health R&D investing in nonprofit product development for HIV/AIDS, malaria, tuberculosis and NTDs.
- Wellcome Trust (governance policies): politically and financially independent foundation funding science and health research.
Other Global Health Organizations
- Access to Medicine Foundation: non-profit organization analysing how pharmaceutical companies are addressing access to medicine. Publishes an Access to Medicine Index and Access to Vaccines Index.
- Engineering World Health: non-profit organization engaging the skills and passions of students and professionals to improve healthcare delivery in low-income countries.
- Global Health Technologies Coalition: coalition of more than 25 non-profit organizations, academic institutions, and aligned businesses advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other tools.
- PATH: organization working on vaccines, drugs, medical devices, diagnostics, digital tools, and innovative approaches to strengthening health systems through partnerships with governments, philanthropists, non-profits and the private sector
- Triangle Global Health Consortium: organization working to establish North Carolina as an international center for research, training, education, advocacy and business dedicated to improving the health of the world’s communities.
- WIPO Re:Search: a public-private consortium led by the World Intellectual Property Organization (WIPO) and BIO Ventures for Global Health (BVGH) catalyzing global health collaborations by making IP available to scientists who need it.
Contracting Resources
- AUTM Global Health Tool Kit: provides examples of how to structure license clauses that promote innovation and product development while encouraging access to essential medicines by developing countries.
- Marshall Gerstein IP: law firm providing intellectual property advice and legal services across a range of industries, including non-profit technology transfer.
- Medicines Law & Policy Tools: provides tools including model licenses and guidance on compulsory licensing.
- Medicines Patent Pool: United Nations-backed public health organization working to pool intellectual property to encourage generic manufacture and the development of new formulations.
- NIH License Policy Agreements: IP document and agreement templates.
